Copyright Reports & Markets. All rights reserved.

Global and Japan Piriformis Syndrome Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Piriformis Syndrome Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Medication
    • 1.2.3 Physical Therapy
    • 1.2.4 Others
  • 1.3 Market by Application
    • 1.3.1 Global Piriformis Syndrome Market Share by Application: 2020 VS 2026
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
    • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Piriformis Syndrome Market Perspective (2015-2026)
  • 2.2 Global Piriformis Syndrome Growth Trends by Regions
    • 2.2.1 Piriformis Syndrome Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Piriformis Syndrome Historic Market Share by Regions (2015-2020)
    • 2.2.3 Piriformis Syndrome Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Piriformis Syndrome Players by Market Size
    • 3.1.1 Global Top Piriformis Syndrome Players by Revenue (2015-2020)
    • 3.1.2 Global Piriformis Syndrome Revenue Market Share by Players (2015-2020)
  • 3.2 Global Piriformis Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Piriformis Syndrome Revenue
  • 3.4 Global Piriformis Syndrome Market Concentration Ratio
    • 3.4.1 Global Piriformis Syndrome Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Piriformis Syndrome Revenue in 2019
  • 3.5 Key Players Piriformis Syndrome Area Served
  • 3.6 Key Players Piriformis Syndrome Product Solution and Service
  • 3.7 Date of Enter into Piriformis Syndrome Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Piriformis Syndrome Breakdown Data by Type (2015-2026)

  • 4.1 Global Piriformis Syndrome Historic Market Size by Type (2015-2020)
  • 4.2 Global Piriformis Syndrome Forecasted Market Size by Type (2021-2026)

5 Piriformis Syndrome Breakdown Data by Application (2015-2026)

  • 5.1 Global Piriformis Syndrome Historic Market Size by Application (2015-2020)
  • 5.2 Global Piriformis Syndrome Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Piriformis Syndrome Market Size (2015-2026)
  • 6.2 North America Piriformis Syndrome Market Size by Type (2015-2020)
  • 6.3 North America Piriformis Syndrome Market Size by Application (2015-2020)
  • 6.4 North America Piriformis Syndrome Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Piriformis Syndrome Market Size (2015-2026)
  • 7.2 Europe Piriformis Syndrome Market Size by Type (2015-2020)
  • 7.3 Europe Piriformis Syndrome Market Size by Application (2015-2020)
  • 7.4 Europe Piriformis Syndrome Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Piriformis Syndrome Market Size (2015-2026)
  • 8.2 China Piriformis Syndrome Market Size by Type (2015-2020)
  • 8.3 China Piriformis Syndrome Market Size by Application (2015-2020)
  • 8.4 China Piriformis Syndrome Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Piriformis Syndrome Market Size (2015-2026)
  • 9.2 Japan Piriformis Syndrome Market Size by Type (2015-2020)
  • 9.3 Japan Piriformis Syndrome Market Size by Application (2015-2020)
  • 9.4 Japan Piriformis Syndrome Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Piriformis Syndrome Market Size (2015-2026)
  • 10.2 Southeast Asia Piriformis Syndrome Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Piriformis Syndrome Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Piriformis Syndrome Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Novartis
    • 11.1.1 Novartis Company Details
    • 11.1.2 Novartis Business Overview
    • 11.1.3 Novartis Piriformis Syndrome Introduction
    • 11.1.4 Novartis Revenue in Piriformis Syndrome Business (2015-2020))
    • 11.1.5 Novartis Recent Development
  • 11.2 Sanofi
    • 11.2.1 Sanofi Company Details
    • 11.2.2 Sanofi Business Overview
    • 11.2.3 Sanofi Piriformis Syndrome Introduction
    • 11.2.4 Sanofi Revenue in Piriformis Syndrome Business (2015-2020)
    • 11.2.5 Sanofi Recent Development
  • 11.3 Bayer
    • 11.3.1 Bayer Company Details
    • 11.3.2 Bayer Business Overview
    • 11.3.3 Bayer Piriformis Syndrome Introduction
    • 11.3.4 Bayer Revenue in Piriformis Syndrome Business (2015-2020)
    • 11.3.5 Bayer Recent Development
  • 11.4 AstraZeneca
    • 11.4.1 AstraZeneca Company Details
    • 11.4.2 AstraZeneca Business Overview
    • 11.4.3 AstraZeneca Piriformis Syndrome Introduction
    • 11.4.4 AstraZeneca Revenue in Piriformis Syndrome Business (2015-2020)
    • 11.4.5 AstraZeneca Recent Development
  • 11.5 Teva Pharmaceuticals
    • 11.5.1 Teva Pharmaceuticals Company Details
    • 11.5.2 Teva Pharmaceuticals Business Overview
    • 11.5.3 Teva Pharmaceuticals Piriformis Syndrome Introduction
    • 11.5.4 Teva Pharmaceuticals Revenue in Piriformis Syndrome Business (2015-2020)
    • 11.5.5 Teva Pharmaceuticals Recent Development
  • 11.6 Endo Pharmaceuticals
    • 11.6.1 Endo Pharmaceuticals Company Details
    • 11.6.2 Endo Pharmaceuticals Business Overview
    • 11.6.3 Endo Pharmaceuticals Piriformis Syndrome Introduction
    • 11.6.4 Endo Pharmaceuticals Revenue in Piriformis Syndrome Business (2015-2020)
    • 11.6.5 Endo Pharmaceuticals Recent Development
  • 11.7 Omron Healthcare
    • 11.7.1 Omron Healthcare Company Details
    • 11.7.2 Omron Healthcare Business Overview
    • 11.7.3 Omron Healthcare Piriformis Syndrome Introduction
    • 11.7.4 Omron Healthcare Revenue in Piriformis Syndrome Business (2015-2020)
    • 11.7.5 Omron Healthcare Recent Development
  • 11.8 DePuy Synthes
    • 11.8.1 DePuy Synthes Company Details
    • 11.8.2 DePuy Synthes Business Overview
    • 11.8.3 DePuy Synthes Piriformis Syndrome Introduction
    • 11.8.4 DePuy Synthes Revenue in Piriformis Syndrome Business (2015-2020)
    • 11.8.5 DePuy Synthes Recent Development
  • 11.9 Miracle Stretch
    • 11.9.1 Miracle Stretch Company Details
    • 11.9.2 Miracle Stretch Business Overview
    • 11.9.3 Miracle Stretch Piriformis Syndrome Introduction
    • 11.9.4 Miracle Stretch Revenue in Piriformis Syndrome Business (2015-2020)
    • 11.9.5 Miracle Stretch Recent Development
  • 11.10 Seirin Corporation
    • 11.10.1 Seirin Corporation Company Details
    • 11.10.2 Seirin Corporation Business Overview
    • 11.10.3 Seirin Corporation Piriformis Syndrome Introduction
    • 11.10.4 Seirin Corporation Revenue in Piriformis Syndrome Business (2015-2020)
    • 11.10.5 Seirin Corporation Recent Development
  • 11.11 Nidd Valley Medical
    • 10.11.1 Nidd Valley Medical Company Details
    • 10.11.2 Nidd Valley Medical Business Overview
    • 10.11.3 Nidd Valley Medical Piriformis Syndrome Introduction
    • 10.11.4 Nidd Valley Medical Revenue in Piriformis Syndrome Business (2015-2020)
    • 10.11.5 Nidd Valley Medical Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Piriformis Syndrome Scope and Market Size
    Piriformis Syndrome market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Piriformis Syndrome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Medication
    Physical Therapy
    Others

    Market segment by Application, split into
    Hospitals
    Clinics
    Others

    Based on regional and country-level analysis, the Piriformis Syndrome market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Piriformis Syndrome market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Novartis
    Sanofi
    Bayer
    AstraZeneca
    Teva Pharmaceuticals
    Endo Pharmaceuticals
    Omron Healthcare
    DePuy Synthes
    Miracle Stretch
    Seirin Corporation
    Nidd Valley Medical

    Buy now